Skip to main content
Clinical Trials/NCT01192425
NCT01192425CompletedNot Applicable

P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes

Alexion Pharmaceuticals, Inc.0 sites5,580 target enrollmentStarted: September 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
5,580

Study Overview

Brief Summary

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
10 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • At least 10 years of age.
  • Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes

Exclusion Criteria

  • Has any condition that might interfere with the patient's participation

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials